{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:05:22Z","timestamp":1790820322775,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human immunodeficiency virus (HIV) remains a major public health challenge, particularly in sub-Saharan Africa, where achieving sustained HIV virologic suppression continues to be difficult despite expanded access to antiretroviral therapy (ART). This challenge is further complicated among people living with HIV-HBV coinfection due to increased disease complexity, treatment burden, and adherence-related barriers. Health education plays an important role in improving adherence and virologic outcomes; however, its implementation remains inconsistent in resource-limited settings. This study explored barriers and enablers to implementing health education for HIV virologic suppression among adults living with HIV-HBV coinfection in Northwest Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to explore the barriers and enablers influencing the implementation of health education for HIV virological suppression among adults living with HIV-HBV co-infection in North-West Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A facility-based interpretive qualitative study was conducted from November 13, 2025, to January 12, 2026, at the University of Gondar Comprehensive Specialized Hospital and Felege Hiwot Comprehensive Specialized Hospital in Northwest Ethiopia. A total of 28 purposively selected participants, including adult people living with HIV-HBV coinfection, healthcare providers, and HIV program managers, participated in in-depth interviews (IDIs), key informant interviews (KIIs), and focus group discussions (FGDs). Data were audio-recorded, transcribed verbatim, translated into English, and analyzed using reflexive thematic analysis with a deductive approach guided by the Consolidated Framework for Implementation Research (CFIR) using MAXQDA Analytics Pro 2024. Trustworthiness was ensured through triangulation, member checking, peer debriefing, and maintaining an audit trail.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten barriers and eight enablers were identified across all CFIR domains. In addition to inaccurate information or graphics and transportation issues, the main reported hurdles included patient-level issues such as inadequate literacy, misconceptions about ART or viral load, anxiety about being seen attending sessions, and limited patient engagement in instructional design. Staff shortages, lack of commitment to counselling duties, a focus on ART refills rather than education, irregular or shortened sessions, lack of time, and the absence of a dedicated budget were all organizational and system-level barriers. Conversely, teamwork, clearly defined staff roles, the use of viral load monitoring tools, frequent review meetings, alignment with national HIV guidelines, patient motivation to achieve viral suppression, trust in provider advice, and improved adherence linked to education were all perceived enablers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Implementation of health education for HIV virological suppression among HIV-HBV co-infected patients is hindered by key barriers, particularly low patient literacy, misconceptions, stigma-related concerns, and systemic challenges such as staff shortages, limited time, and inadequate resources. However, strong teamwork, patient motivation, provider trust, and alignment with national guidelines serve as important enablers. Findings from this study informed the updating of the existing health education intervention to better address identified barriers and strengthen enabling factors. Testing the revised intervention for feasibility and acceptability is essential before wider implementation to improve adherence and achieve sustained HIV virological suppression in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-026-00922-0","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:44:38Z","timestamp":1783352678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers and enablers to implementing health education for HIV virologic suppression among adult people living with HIV-HBV coinfection in Northwest Ethiopia: a consolidated framework for implementation research guided qualitative study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-8425","authenticated-orcid":false,"given":"Mequanente","family":"Dagnaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destaw Fetene","family":"Teshome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilahun Bizuayehu","family":"Demass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebaw Gebyehu","family":"Worku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"922_CR1","unstructured":"UNAIDS, UNAIDS Global AIDSU. 2024: The Urgency of Now: AIDS at a Crossroads: Stylus Publishing, LLC; 2024."},{"key":"922_CR2","unstructured":"Organization WH. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. World Health Organization; 2021."},{"issue":"S5","key":"922_CR3","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/hep.22883","volume":"49","author":"CL Thio","year":"2009","unstructured":"Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(S5):S138\u201345.","journal-title":"Hepatology"},{"key":"922_CR4","doi-asserted-by":"crossref","unstructured":"Liu Y, Yuan X, Ji F. More expansive diagnosis and treatment are urgently needed to eliminate the global burden of HBV. Lancet Reg Health Am. 2024;36:100843.Liu Y, Yuan X, Ji F. More expansive diagnosis and treatment are urgently needed to eliminate the global burden of HBV. Lancet Reg Health\u2013Americas. 2024;36.","DOI":"10.1016\/j.lana.2024.100843"},{"issue":"6","key":"922_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/cid\/ciad654","volume":"78","author":"MJ Vinikoor","year":"2024","unstructured":"Vinikoor MJ, Hamusonde K, Muula G, Asombang M, Riebensahm C, Chitundu H, et al. Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV\/HIV coinfection in Zambia. Clin Infect Dis. 2024;78(6):1583\u201390.","journal-title":"Clin Infect Dis"},{"key":"922_CR6","doi-asserted-by":"crossref","unstructured":"Reyed RM, Prabhakar PK. Personalized antiviral therapy tailoringtreatments to genetic environmental and lifestyle factors. Global perspectives on antiviral drug development. IGI Global Scientific Publishing; 2025. pp. 63\u2013138.","DOI":"10.4018\/979-8-3693-9276-8.ch003"},{"issue":"4","key":"922_CR7","doi-asserted-by":"publisher","first-page":"e00104","DOI":"10.1128\/mmbr.00104-25","volume":"89","author":"Y Li","year":"2025","unstructured":"Li Y, Xiao Q, Yu F, Zhang F. HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression? Microbiol Mol Biol Rev. 2025;89(4):e00104\u201325.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"922_CR8","doi-asserted-by":"publisher","first-page":"e2540","DOI":"10.1002\/rmv.2540","volume":"34","author":"IH Mosha","year":"2024","unstructured":"Mosha IH, Nyondo GG, Munishi CG, Njiro BJ, Bwire GM. Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub\u2010Saharan Africa: A systematic review and meta\u2010analysis. Rev Med Virol. 2024;34(3):e2540.","journal-title":"Rev Med Virol"},{"issue":"1","key":"922_CR9","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2352-3018(16)30206-5","volume":"4","author":"S Kanters","year":"2017","unstructured":"Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. lancet HIV. 2017;4(1):e31\u201340.","journal-title":"lancet HIV"},{"issue":"12","key":"922_CR10","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(11)70181-5","volume":"11","author":"T B\u00e4rnighausen","year":"2011","unstructured":"B\u00e4rnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell M-L. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011;11(12):942\u201351.","journal-title":"Lancet Infect Dis"},{"key":"922_CR11","doi-asserted-by":"publisher","first-page":"205520761877140","DOI":"10.1177\/2055207618771407","volume":"4","author":"N Konduri","year":"2018","unstructured":"Konduri N, Aboagye-Nyame F, Mabirizi D, Hoppenworth K, Kibria MG, Doumbia S, et al. Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals. Digit Health. 2018;4:2055207618771407.","journal-title":"Digit Health"},{"issue":"3","key":"922_CR12","doi-asserted-by":"publisher","first-page":"e1003940","DOI":"10.1371\/journal.pmed.1003940","volume":"19","author":"A Mirzazadeh","year":"2022","unstructured":"Mirzazadeh A, Eshun-Wilson I, Thompson RR, Bonyani A, Kahn JG, Baral SD, et al. Interventions to reengage people living with HIV who are lost to follow-up from HIV treatment programs: a systematic review and meta-analysis. PLoS Med. 2022;19(3):e1003940.","journal-title":"PLoS Med"},{"issue":"1","key":"922_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12913-019-4015-3","volume":"19","author":"P Nilsen","year":"2019","unstructured":"Nilsen P, Bernhardsson S. Context matters in implementation science: a scoping review of determinant frameworks that describe contextual determinants for implementation outcomes. BMC Health Serv Res. 2019;19(1):189.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"922_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"issue":"1","key":"922_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13012-020-0977-0","volume":"15","author":"AR Means","year":"2020","unstructured":"Means AR, Kemp CG, Gwayi-Chore M-C, Gimbel S, Soi C, Sherr K, et al. Evaluating and optimizing the consolidated framework for implementation research (CFIR) for use in low-and middle-income countries: a systematic review. Implement Sci. 2020;15(1):17.","journal-title":"Implement Sci"},{"issue":"1","key":"922_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13104-019-4279-z","volume":"12","author":"GM Belay","year":"2019","unstructured":"Belay GM, Engeda EH, Ayele AD. Late antiretroviral therapy initiation and associated factors among children on antiretroviral therapy at University of Gondar Comprehensive Specialized Hospital, Gondar, Northwest Ethiopia: a cross-sectional study. BMC Res Notes. 2019;12(1):255.","journal-title":"BMC Res Notes"},{"issue":"1","key":"922_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12981-021-00418-z","volume":"18","author":"TG Amera","year":"2021","unstructured":"Amera TG, Bogale KA, Tefera YM. Time to initial highly active antiretroviral therapy discontinuation and its predictors among HIV patients in Felege Hiwot comprehensive specialized hospital: a retrospective cohort study. AIDS Res therapy. 2021;18(1):93.","journal-title":"AIDS Res therapy"},{"issue":"1","key":"922_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13012-017-0550-7","volume":"12","author":"RE Keith","year":"2017","unstructured":"Keith RE, Crosson JC, O\u2019Malley AS, Cromp D, Taylor EF. Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation. Implement Sci. 2017;12(1):15.","journal-title":"Implement Sci"},{"key":"922_CR19","unstructured":"Organization WH. Overview of WHO recommendations on HIV and sexually transmitted infection testing, prevention, treatment, care and service delivery. 2025."},{"issue":"8","key":"922_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/cid\/cit420","volume":"57","author":"MJ Mugavero","year":"2013","unstructured":"Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164\u201371.","journal-title":"Clin Infect Dis"},{"key":"922_CR21","volume-title":"Aging with HIV: A Qualitative Exploration of Disease Burden","author":"EP Van Bremen","year":"2026","unstructured":"Van Bremen EP. Aging with HIV: A Qualitative Exploration of Disease Burden. Healthcare Access, and Quality of Life: Thomas Jefferson University; 2026."},{"issue":"5","key":"922_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"RW Eisinger","year":"2019","unstructured":"Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451\u20132.","journal-title":"JAMA"},{"key":"922_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fpubh.2019.00158","volume":"7","author":"ME Fernandez","year":"2019","unstructured":"Fernandez ME, Ten Hoor GA, Van Lieshout S, Rodriguez SA, Beidas RS, Parcel G, et al. Implementation mapping: using intervention mapping to develop implementation strategies. Front public health. 2019;7:158.","journal-title":"Front public health"},{"issue":"1","key":"922_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/tropicalmed11010005","volume":"11","author":"LR Chang","year":"2025","unstructured":"Chang LR, Gutierrez C, Rodas J, Aitcheson N, Farach N, Castaneda C, et al. Analysis of Adolescent HIV Care Cascade Outcomes in PEPFAR-Supported Programs in Central America, October 2020\u2013September 2024. Trop Med Infect Disease. 2025;11(1):5.","journal-title":"Trop Med Infect Disease"},{"key":"922_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fpubh.2019.00003","volume":"7","author":"BJ Powell","year":"2019","unstructured":"Powell BJ, Fernandez ME, Williams NJ, Aarons GA, Beidas RS, Lewis CC, et al. Enhancing the impact of implementation strategies in healthcare: a research agenda. Front public health. 2019;7:3.","journal-title":"Front public health"},{"issue":"1","key":"922_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1748-5908-8-139","volume":"8","author":"EK Proctor","year":"2013","unstructured":"Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013;8(1):139.","journal-title":"Implement Sci"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00922-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:49:58Z","timestamp":1790819398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00922-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00922-0","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance for this study was obtained from the Institutional Research Ethics Review Committee (IRERC) (Ref: College of Medicine and Health Sciences, and Specialized Hospital-University of Gondar-Institutional Research Ethics Review Committee\/108\/11\/2025; dated 12 November 2025). Written informed consent was obtained from all participants prior to their inclusion in the study. Participant confidentiality was strictly maintained through the use of coded identifiers, and all data were securely stored with access limited to authorized personnel only. Interviews were conducted in a private setting to ensure privacy and comfort. Participation in the study was entirely voluntary, and participants were informed of their right to withdraw at any time without any consequences to their care or services. The study was conducted in accordance with the principles of the Declaration of Helsinki, as well as applicable national and institutional ethical guidelines. Written informed consent was obtained after explaining the study, risks\/benefits, confidentiality, and the right to withdraw without affecting care. For illiterate participants, consent was read in the local language and documented by thumbprint with a witness. Questions were addressed before interviews.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}